Skip to main content

HHS sponsors new formulation of world’s first approved smallpox drug

Submitted by lsekela on September 28, 2018 - 09:07 AM

To expand US health security and prepare for the potential use of smallpox virus in bioterrorism attacks against the United States, the US Department of Health and Human Services (HHS) will purchase additional doses of a smallpox antiviral medication called TPOXX for the Strategic National Stockpile and will work with Siga Technologies to develop an intravenous formulation of the drug.

Content Source:

US Department of Health and Human Services (HHS)

Content Author:

unknown

Tags: